Hypothesis

Senescent neutrophils in the aged intestine release matrix metalloproteinase‑9 (MMP‑9) that selectively degrades the O‑glycan rich mucin domains, truncating glycan chains and exposing the protein core to bacterial proteases. This enzymatic remodeling creates a mucus environment that is permissive for pathobionts but hostile to the mucin‑specialist Akkermansia muciniphila, whose colonization depends on intact O‑glycan structures for binding and nutrient acquisition. Consequently, the immune system actively drives the loss of its own beneficial symbiont, establishing a feed‑forward loop of barrier decline, inflammaging, and further immune senescence.

Mechanistic Rationale

• Mucin O‑glycans as Akkermansia ligands: A. muciniphila utilizes mucin O‑glycans as both carbon source and adhesion receptors; structural studies show that specific GalNAc‑O‑serine/threonine motifs are required for efficient binding [6]
• Senescent neutrophil secretory profile: Aging is associated with accumulation of senescent neutrophils that exhibit a senescence‑associated secretory phenotype (SASP) rich in MMP‑9, elastase, and cathepsin G [3]
• MMP‑9 mucinolytic activity: MMP‑9 cleaves the peptide backbone of Muc2 upstream of O‑glycosylation sites, leading to loss of glycan chains and increased susceptibility to bacterial sialidases and proteases [1]
• **Feedback to immune dysregula

Hypothesis

Aged limbal epithelial stem cells (LESCs) lose regenerative capacity not because telomerase activity declines, but because they lack the germline’s cyclic epigenetic reprogramming and robust proteostatic surveillance. Transient induction of germline reprogramming factors (Blimp1/Prdm14/Tfap2c) combined with pharmacological autophagy activation will restore LESC colony‑forming efficiency (CFE), reduce epigenetic drift, and ameliorate proteotoxic stress in donors over 60 years old.

Mechanistic Rationale

• LESCs retain telomerase activity and telomere length yet show CFE loss after age 60 [1][2], indicating a telomere‑independent failure.
• The germline safeguards integrity through waves of epigenetic erasure in primordial germ cells, mediated by Blimp1, Prdm14, and Tfap2c, which reset DNA methylation and histone marks to a naïve state [3]. No comparable resetting has been documented in LESCs.
• Germline cells also maintain heightened autophagy and chaperone networks (e.g., LAMP2A, HSP70) that clear damaged proteins and organelles [6][7]. In LESCs, PAX6‑dependent nucleocytoplasmic transport offers only partial protection under UV stress, and age‑related decline in autophagy has not been quantified.
• Niche degradation (flattened palisades of Vogt, loss of KGF, stromal signaling) exacerbates intrinsic deficits but does not explain why telomerase‑positive LESCs still fail [2][5].
• Introducing germline reprogramming factors could temporarily erase age‑associated epigenetic marks (e.g., H3K9me3, 5‑mC at differentiation loci) while autophagy inducers (e.g., sperm

Hypothesis

In gastric cancers exhibiting the alanine-aspartate-glutamate (AAG) metabolic subtype, elevated extracellular aspartate acts as an immunosuppressive signal that binds NMDA‑receptor‑like channels on tumor‑associated macrophages, triggering calcium‑dependent NFAT activation and up‑regulation of PD‑L1. Pharmacologic blockade of aspartate uptake (e.g., via SLC1A3/GLAST inhibitors) will reduce macrophage PD‑L1 expression and enhance the efficacy of anti‑PD‑1 therapy, improving progression‑free survival specifically in AAG‑high patients.

Mechanistic Rationale

Multi‑omics integration has shown that the AAG subgroup derives survival advantage from altered amino‑acid flux, yet the functional consequence of aspartate secretion remains unexplored [2]. Aspartate is a known excitatory neurotransmitter that can activate NMDA‑type receptors on non‑neuronal cells, leading to intracellular calcium spikes and downstream transcriptional programs [1]. Spatial proteomics of colorectal tumors has demonstrated the capacity to map metabolite‑immune interactions at single‑cell resolution, a technique readily adaptable to gastric tissue [3]. We hypothesize that aspartate released by AAG‑high cancer cells engages NMDA‑receptor‑like complexes on CD68⁺ macrophages, causing Ca²⁺ influx, calmodulin‑dependent kinase activation, and NFAT translocation to the nucleus, where it drives CD274 (PD‑L1) transcription. This creates a localized immune‑checkpoint‑rich niche that blunts T‑cell cytotoxicity despite checkpoint blockade.

Experimental Design

1. Cohort assembly – Prospectively

Hypothesis\n\nGermline mitochondria maintain low heteroplasmy not only through bottleneck selection but also via germline‑enriched mitochondrial‑derived peptides (MDPs) that directly modulate mitophagy and Balbiani body formation, thereby acting as a selective editing budget for somatic‑like quality control.\n\n## Rationale\n\n- The germline avoids age‑related mtDNA mutation accumulation seen in somatic tissue after 70 y (1).\n- SHLP2/3 reduce ROS and improve metabolism in vitro (2); humanin extends C. elegans lifespan via FOXO‑dependent autophagy (3).\n- No data exist on MDP expression in primordial germ cells (PGCs) or oocytes, nor on their role in the mitochondrial bottleneck.\n\n## Mechanistic Insight\n\nWe propose that a subset of MDPs—particularly SHLP2 and humanin—are transcriptionally up‑regulated in PGCs and early oocytes, where they:\n1. Bind yet‑uncharacterized receptors on the outer mitochondrial membrane to amplify PINK1‑Parkin mitophagy, preferentially eliminating organelles with high heteroplasmy.\n2. Interact with Balbiani body components (e.g., Bucky ball) to tether damaged mitochondria for sequestration and subsequent lysosomal degradation.\n3. Activate a germline‑specific FOXO‑autophagy axis that couples nutrient sensing to mtDNA quality control, effectively granting somatic cells a germline‑grade editing budget when ectopically expressed.\n\n## Testable Predictions\n\n1. Expression: RT‑qPCR and targeted p

Hypothesis

Chronic mTOR inhibition in aged organisms locks monocytes into a epigenetically trained, glycolytic state that exacerbates inflammaging, whereas intermittent mTOR inhibition paired with selective HDAC3 inhibition resets maladaptive chromatin marks while preserving the beneficial metabolic reprogramming needed for adaptive memory formation.

Rationale

• mTORC1 suppression mimics nutrient stress and drives monocyte training via HIF1α‑dependent aerobic glycolysis and H3K4me3/H3K27Ac accumulation at innate immune promoters [3].
• Aging already loads monocytes with proinflammatory H3K27Ac and H3K4me3 marks [4]. Continuous mTOR inhibition adds a metabolic constraint on top of this pre‑existing landscape, preventing the natural ebb‑flow of training and tolerance that occurs during fluctuating nutrient availability.
• HDAC3 removes acetyl groups from H3K27Ac and is recruited to promoters of NF‑κB target genes during resolution of inflammation. Pharmacological HDAC3 inhibition has been shown to erase trained immunity phenotypes in vitro without affecting oxidative phosphorylation [2].
• Intermittent rapamycin dosing reproduces the pulsatile mTORC1 activity seen during caloric restriction cycles, allowing periods of mTORC1 reactivation that support stem‑cell regeneration and adaptive memory precursor formation [5].

We propose that the co

Hypothesis

The differential accumulation of 4‑hydroxynonenal (HNE) and malondialdehyde (MDA) adducts on mitochondrial proteins across tissues and mouse strains is not solely dictated by intrinsic protein nucleophilicity but is actively regulated by the local antioxidant capacity of mitochondrial peroxiredoxin‑3 (Prdx3). Prdx3 scavenges lipid‑derived electrophiles through its peroxidatic cysteine, thereby reducing the effective concentration of HNE/MDA available for adduct formation. Simultaneously, Prdx3 influences the microenvironmental pH and redox state of nearby protein thiols, altering cysteine pKa and the fraction of reactive thiolate anions. Consequently, strains or tissues with higher mitochondrial Prdx3 activity exhibit lower adduct burden on susceptible complexes (e.g., Complex I NDUFS1, Complex II SDHA/SDHB), whereas Prdx3 deficiency leads to exaggerated adduct accumulation, accelerated respiratory dysfunction, and premature senescence phenotypes.

Mechanistic Reasoning

1. Electrophilic Competition – Prdx3’s peroxidatic cysteine reacts with HNE/MDA at rates comparable to those of protein thiols. By acting as a preferential sink, Prdx3 lowers the steady‑state electrophile flux that reaches vulnerable lysines/cysteines on respiratory chain enzymes.
2. pKa Modulation – Prdx3 cycles between oxidized (disulfide) and reduced (dithiol) states, consuming protons and generating local alkaline microenvironments during its catalytic cycle. This shifts the pKa of neighboring protein cysteines toward lower values, increasing thiolate reactivity only when Prdx3

Hypothesis

Senescent myeloid cells actively promote extracellular matrix (ECM) stiffening in aged tissues by shifting the MMP/TIMP balance toward inhibition through a hypoxia-inducible factor‑1α (HIF‑1α)–dependent metabolic program. This shift increases TIMP‑1 secretion and suppresses MMP‑9 activity, leading to collagen cross‑link accumulation and impaired tissue regeneration. Reversing HIF‑1α activation in senescent myeloid cells—or clearing these cells—will restore proteolytic equilibrium, reduce ECM stiffening, and ameliorate age‑related functional decline.

Mechanistic Rationale

1. Metabolic reprogramming in senescent myeloid cells – Persistent DNA damage and mitochondrial ROS in aged neutrophils and monocytes stabilize HIF‑1α, even under normoxic conditions. HIF‑1α directly binds the TIMP‑1 promoter, enhancing its transcription, while recruiting histone deacetylases to the MMP-9 locus, suppressing its expression [2].
2. Proteolytic imbalance – Elevated TIMP-1 inhibits MMP-9, tipping the net proteolytic activity toward matrix deposition. This aligns with observed age‑related rises in plasma TIMP-1 (728 ng/ml → 1093 ng/ml) and declines in MMP-9 activity, which favor concentric remodeling and diastolic dysfunction [https://pmc.ncbi.nlm.nih.gov/articles/PMC2698433/], [https://pubmed.ncbi.nlm.nih.gov/17826643/].
3. ECM consequences – Reduced MMP-9 limits collagen fibrillolysis, while unchecked TIMP-1 permits lysine glycation and AGE formation on collagen fibers. AGE‑RAGE signaling on immune cells further amplifies inflammation, creating a feed‑forward loop

Hypothesis

Increasing mitochondrial DNA (mtDNA) copy number in post‑mitotic tissues restores a youthful nuclear epigenetic landscape by normalizing retrograde ROS‑NAD+ signaling, thereby delaying age‑related decline independent of nuclear genome editing.

Mechanistic Rationale

mtDNA mutations accumulate with age and trigger focal respiratory defects that elevate local ROS [1][2]. This ROS surge consumes NAD+ through PARP activation, lowering the NAD+/NADH ratio and dampening SIRT1 activity [3]. SIRT1 normally deacetylates histones and transcription factors such as NF‑κB and PGC‑1α, maintaining a chromatin state conducive to mitochondrial biogenesis and stress resistance [4]. When SIRT1 wanes, histone acetylation rises at promoters of inflammatory genes, while PGC‑1α activity falls, creating a vicious cycle of mito‑nuclear mismatch.

Boosting mtDNA copy number—via TFAM overexpression or enhanced mito‑biogenesis—dilutes the proportion of mutated genomes, reduces ROS per mitochondrion, and raises total NAD+ production. The improved NAD+/NADH ratio reactivates SIRT1, which then re‑establishes youthful acetylation patterns on nuclear chromatin. In this view, mtDNA acts as a metabolic rheostat that sets the epigenetic tempo of the nucleus, rather than merely a passive damage target.

Predictions & Experimental Design

1. Rescue of heteroplasmy impact: In mtDNA‑mutator mice (PolG^D257A/D257A), AAV9‑mediated TFAM delivery to skeletal muscle will increase mtDNA copy number by ~2‑fold and lower heteroplasmy levels at COX‑deficient fibers from >70% to <30% after 8 weeks

Hypothesis

Carriers of the CRY1-GoF variant exhibit delayed melatonin onset and prolonged REM latency, which blunts the early-night testosterone pulse. Timed bright-light exposure administered within 30 min of habitual wake time will advance the circadian phase, shorten REM latency, and restore the testosterone surge, whereas the same intervention will have minimal effect in non-carriers.

Mechanistic Rationale

• The CRY1-GoF mutation lengthens the circadian period by increasing repression of Clock/Bmal1 transcription, shifting the phase of downstream genes such as Per1 and Bmal1 in the suprachiasmatic nucleus ([2]).
• This shift delays the evening rise of melatonin, which in turn postpones the transition from NREM to REM sleep, increasing latency to the first REM episode ([1]).
• Testosterone secretion is tightly coupled to the first REM episode; a longer latency reduces the amplitude of the early nocturnal pulse ([1]).
• Morning bright light activates melanopsin retinal ganglion cells, causing a phase-advance of the suprachiasmatic clock via rapid degradation of CRY proteins and induction of Per1 ([5]).
• In CRY1-GoF carriers, the excess CRY1 protein requires stronger light-induced degradation to achieve a comparable phase shift, predicting a genotype-dependent dose-response to light therapy.

Predictions

1. In a crossover study, CRY1-GoF carriers receiving 30 min of 10000 lux light at 07:00 will show:
   • A >=15% advance in dim-light melatonin onset (DLMO) within 3 days.

Hypothesis

Centrosome amplification (CA) in aged somatic cells increases astral microtubule nucleation, which serves as a scaffold to reposition lysosomes near the perinuclear region, thereby enhancing Rag GTPase‑mediated mTORC1 activation on lysosomal surfaces. This mTORC1 surge selectively translates a subset of SASP factors (IL‑6, IL‑8, ANGPTL4) through a HIF1α‑independent, Rac1‑ROS axis, promoting a pro‑invasive, senescence‑escape phenotype that can occur even when centrosome clustering prevents multipolar mitosis.

Mechanistic Rationale

1. Microtubule nucleation as a spatial regulator – Amplified centrosomes generate excess astral microtubules that bind dynein/dynactin complexes, pulling lysosomes toward the microtubule‑organizing center. Prior work shows microtubule density correlates with lysosomal clustering and mTORC1 signaling (3).
2. Lysosomal mTORC1 drives a distinct SASP – mTORC1 phosphorylates 4EBP1 and S6K, favoring cap‑dependent translation of mRNAs with complex 5’UTRs, including those encoding IL‑6, IL-8, and ANGPTL4 (4). This bypasses the canonical NF‑κB/DNA‑damage SASP pathway described in the variant SASP via Rac1‑ROS‑HIF1α‑ANGPTL4.
3. Rac1‑ROS amplification loop – Increased microtubule nucleation also elevates Rac1 GEF activity at microtubule plus‑ends, augmenting ROS production that further stabilizes HIF1α and amplifies ANGPTL4 transcription ([5](https://cellbio.hms.harvard.edu/news/pellman-lab-finds-centrosome-amplification-m

We hypothesize that the circadian-driven pulsatile secretion of GLP-1 from duodenal L-cells acts as a systemic timing cue that preserves thymic epithelial function and naive T‑cell output, and that loss of this rhythm accelerates immunosenescence. Recent work shows that gut hormone secretion, including GLP-1, is tightly regulated by circadian rhythms and that microbial metabolites like SCFAs act as timing cues influencing enteroendocrine function and host clocks [Frontiers Microbiology 2025]. The gastrointestinal tract also exhibits circadian control over digestion, absorption, and expression of nutrient transporters such as PEPT1 and NHE3 [PMC6533073]. Yet no study has examined whether the circadian amplitude of the molecular clock in duodenal L-cells declines with age, or how that impacts GLP-1 pulsatility and downstream thymic homeostasis.

Mechanistically, we propose that GLP-1 binds to GLP-1R on thymic epithelial cells (TECs), raising cAMP and activating PKA‑CREB signaling, which sustains FOXN1 expression—a master regulator of TEC differentiation and thymopoiesis. Concurrently, GLP-1‑stimulated cAMP enhances NAD+ synthesis via SIRT1 activation, reducing oxidative stress in TECs and preserving the cortical‑medullary balance required for positive and negative selection. When duodenal L‑cell clock genes (Bmal1, Clock, Per2) lose amplitude, GLP-1 secretion becomes arrhythmic, depriving TECs of timed trophic signals. This leads t

Hypothesis

We hypothesize that a brief, intermittent inhibition of the IL‑1α/IL‑1β feedback loop that drives the transition from immunosuppressive to pro‑inflammatory SASP will 'prime' senescent cells for subsequent senolytic clearance while preserving the early, tissue‑reparative SASP phase. This two‑step regimen—first a senomorphic that blocks IL‑1α signaling (e.g., neutralizing antibody or small‑molecule IL‑1R antagonist), followed after a defined interval by a senolytic targeting SCAPs (e.g., navitoclax)—should increase the proportion of senescent cells eliminated in aged tissues, reduce off‑target toxicity, and retain beneficial transient senescence in wound healing.

Mechanistic Rationale

1. SASP temporal switch – Early SASP is dominated by TGF‑β1/3 and is immunosuppressive/pro‑fibrotic; later SASP shifts to IL‑1β, IL‑6, IL‑8 via an IL‑1α autocrine loop that activates NF‑κB and cGAS‑STING [2]. Inhibiting IL‑1α/IL‑1R prevents this feed‑forward, locking cells in the early SASP state.
2. SCAP dependence – Early SASP senescent cells retain high BCL‑2/BCL‑xL expression but lower dependence on Src‑family kinases; late SASP upregulates MCL‑1 and BFL‑1, altering SCAP profiles [1]. Priming with IL‑1 blockade may maintain BCL‑2/BCL‑xL dominance, making cells more sensitive to navitoclax.
3. Preservation of beneficial senescence – Transient senescence in wound healing relies on early SASP to recruit macrophages and stimulate matrix deposition without chronic inflammation [4]. By blocking the IL‑1α‑driven switch, we impede the deleterious late SASP while leavi

Hypothesis

Intermittent dosing of dasatinib plus quercetin (D+Q) guided by dynamic SASP biomarker levels will achieve sustained senescent cell clearance without triggering compensatory epigenetic aging, whereas fixed‑interval regimens either under‑dose (allowing SASP rebound) or over‑dose (inducing off‑target epigenetic stress).

Mechanistic Rationale

• D+Q clears senescent cells and transiently suppresses SASP IL‑6, CXCL1, MCP‑1 2.
• SASP suppression lifts inhibitory feedback on NF‑κB and JAK/STAT pathways in neighboring cells, promoting a rebound surge of SASP factors within 48–72 h post‑withdrawal (observed as mRNA‑level persistence but protein‑level rise) 2.
• Repeated SASP spikes drive chronic low‑grade inflammation that activates DNMT3A and TET2 in immune cells, accelerating epigenetic age as seen in first‑generation clocks after prolonged D+Q exposure 9.
• Adaptive dosing that re‑administers D+Q at the onset of SASP protein rise (≥25 % increase from nadir) would maintain suppression before the inflammatory feedback loop engages, limiting epigenetic drift.

Testable Predictions

1. In aged mice, serum MCP‑1, IL‑6, and CXCL1 will show a predictable nadir 24 h post‑D+Q followed by a reproducible rebound peak at 60 h.
2. Mice receiving D+Q only when SASP biomarkers cross a predefined upward threshold will exhibit (a) lower cumulative senescent cell burden (p16^INK4a^+ cells by flow cytometry) after 6 months th

Hypothesis

Transiently generated senescent fibroblasts in acute wounds create a regenerative niche by secreting morphogenetic factors that guide neighboring stem cells; removing these cells with senolytics during the early repair phase impairs this signaling and delays tissue restoration.

Mechanistic Rationale

Young wound fibroblasts that become p16+/p21+/Mki67− senescent activate developmental gene programs enriched for morphogenetic pathways [1]. These cells secrete a distinct SASP fraction rich in fibroblast growth factors, Wnt modulators, and matrix remodeling enzymes that collectively establish a permissive microenvironment for epithelial and stem‑cell proliferation. In contrast, chronic senescent cells produce a proinflammatory SASP that drives fibrosis. The temporal switch from a regenerative to a deleterious SASP is governed by intracellular NAD+ levels and chromatin accessibility at enhancers of SASP genes; acute injury transiently lowers NAD+, favoring a benign SASP, while persistent oxidative stress maintains high NAD+ and locks in a harmful profile.

Testable Predictions

1. Senolytic treatment administered within 24 h post‑injury will reduce the proportion of p16+/p21+/Mki67− fibroblasts in the wound granulation tissue by >50 % compared with vehicle.
2. This reduction will correlate with a measurable decrease in wound‑area closure rate at day 7 (∼30 % slower) and diminished expression of morphogenetic markers (e.g., Fgf7, Wnt5a) in the surrounding tissue.
3. Exogenous addition of the putative regenerative

The longevity benefit observed in XX individuals stems from dynamic remodeling of X‑inactivation that reactivates normally silent X‑linked genes in steroidogenic cells, thereby enhancing StAR‑mediated cholesterol import and protecting against oxidative damage; failure of this reactivation accelerates Leydig cell senescence, lowers testosterone output, and shortens lifespan.

Mechanistic rationale

• Approximately 15 % of X‑linked genes escape inactivation in females, including antioxidant enzymes such as G6PD and XIAP that mitigate reactive‑oxygen‑species (ROS) production[3]. With age, additional X‑linked loci escape silencing in the brain[4], suggesting a similar epigenetic drift occurs in Leydig cells.
• Reactivated escapees can include lipid‑traffic regulators (e.g., STARD3, NPC1) that facilitate cholesterol delivery to the mitochondrial inner membrane where StAR catalyzes the rate‑limiting step of testosterone biosynthesis. Elevated expression of these genes would increase StAR activity and steroid output, preserving testicular endocrine function.
• In XY cells, a single X chromosome cannot provide sufficient biallelic expression of these protective loci, leading to chronic ROS accumulation, StAR oxidative inhibition, and progressive Leydig cell dysfunction. This aligns with the observation that males exhibit earlier onset of testicular aging despite comparable gonadotropin drive.
• The XXY karyotype in Klinefelter syndrome creates a paradox: an extra X chromoso

The circadian clock does more than time metabolic cycles; it drives a daily phosphorylation cycle of nuclear lamina proteins that preserves chromatin compartmentalization. When this rhythm damps with age, lamina becomes hypophosphorylated, heterochromatin loosens, and DNA damage sensing pathways fire incessantly, feeding the inflammaging loop. Restoring the lamina‑phosphorylation rhythm should therefore re‑establish temporal chromatin integrity and delay multiple age‑related phenotypes.

Core Mechanistic Claim

Core clock‑controlled transcription of the kinase CK1δ (and its activator PPP1R12B) peaks in the early subjective night, producing a wave of lamina‑associated polypeptide (LAP2β) phosphorylation that transiently opens chromatin at repair‑gene loci. As the clock output wanes, CK1δ rhythm flattens, lamina stays dephosphorylated, and repair genes lose their periodic accessibility. This loss of temporal gating explains why epigenetic drift shows strong overlap with circadian‑regulated sites 3 and why phase shifts of Per1/Per2 coincide with increased DNA‑damage markers in aged brain 6.

Testable Predictions

1. Rhythmic lamina phosphorylation declines in aged tissues. Quantitative phospho‑proteomics of LAP2β from young vs. old mouse liver, muscle, and microglia will show a >50 % reduction in amplitude of the nocturnal phosphorylation peak.
2. Forced CK1δ rhythm rescues chromatin state. Viral delivery of a CK1δ construct driven by a synthetic circadian promoter (Bm

Hypothesis: NAD+ Directly Regulates Translation Initiation Through eIF4E-BP to Enforce a Metabolic Thrift State

We propose that falling NAD+ levels act as a direct signal to the translation machinery, promoting a thrift state that limits anabolic growth. This response is protective early in life by curbing unchecked proliferation and reducing replication‑associated DNA damage. With advancing age, however, the same mechanism becomes maladaptive because sustained suppression of protein synthesis erodes mitochondrial biogenesis, repair capacity, and stress‑resilient proteostasis, feeding into the phenotypes described in the NAD+ depletion literature.[1][2]

Mechanistic Basis

Recent structural work shows that the N‑terminal domain of eukaryotic initiation factor 4E‑binding protein (4E‑BP) harbors a conserved Rossmann‑fold motif capable of binding nicotinamide adenine dinucleotide.[3] We hypothesize that NAD+ binding stabilizes the hypophosphorylated, active form of 4E‑BP, which sequesters eIF4E and inhibits cap‑dependent translation. When NAD+ declines, less ligand is available, shifting the equilibrium toward the phosphorylated, inactive state of 4E‑BP and thereby releasing translational repression. Conversely, high NAD+ favors the active repressor form, lowering global protein synthesis.

This model flips the usual view: rather than NAD+ loss merely removing a cofactor for sirtuins, it directly alters a translational checkpoint that couples cellular energy status to growth‑promoting programs. The thrift state would reduce ribosome load, lower ATP consumption,